Evaluation of a new diagnostic method for colorectal cancer

Updated: 3 months ago
Deadline: 11 Nov 2020

The project subject of the research grant, plans to validate the CELTiC panel as a new screening test with the simultaneous measurement of the expression levels of a panel of 4 (mRNA) markers, CEACAM6, LGALS4, TSPAN8 and COL1A2 in the blood. It is part of an area of ??novelty as the 2 currently existing tests are based either on a stool sample or on an endoscopic investigation. The CELTiC test is potentially an alternative to the FIT *, or a replacement and an improvement * due to the potential to identify the subjects who are falsely positive for the FIT screening test.


View or Apply

Similar Positions